Synthetic Vaccines against Friend Murine Leukaemia Virus-induced Erythroleukaemia: in vivo and in vitro Studies with Synthetic Oligopeptides and Sequence-specific Antisera

References

1. Anderer F. A., Schlumberger H. D. 1965; Properties of different artificial antigens immunologically related to tobacco mosaic virus. Biochimica et biophysica acta 97:503–509
   [Google Scholar]
2. Bayer H., Gruber W., Schneider J., Hunsmann G. 1984; Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides. EMBO Journal 3:1925–1930
   [Google Scholar]
3. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A. 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature; London: 29830–33
   [Google Scholar]
4. Chesebro B., Wehrly K., Cloyd M., Britt W., Portis J., Collins J., Nishio J. 1981; Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131–144
   [Google Scholar]
5. Emini E., Bradford A. J., Winkler E. 1983; Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature; London: 304699–703
   [Google Scholar]
6. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
   [Google Scholar]
7. Friend C. 1957; Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. Journal of Experimental Medicine 105:307–318
   [Google Scholar]
8. Göbel W. F. 1939; Studies on antibacterial immunity induced by artificial antigens. I. Immunity to experimental pneumococcal infection with an antigen containing cellobiuronic acid. Journal of Experimental Medicine 69:353–364
   [Google Scholar]
9. Hunsmann G. 1985; Subunit vaccines against exogenous retroviruses: overview and perspectives. Cancer Research (Suppl) 45:4691s–4693s
   [Google Scholar]
10. Hunsmann G., Moennig V., Schäfer W. 1975; Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral gp71 glycoprotein and its corresponding antiserum. Virology 66:327–329
    [Google Scholar]
11. Hunsmann G., Claviez M., Mönnig V., Schwarz H., Schäfer W. 1976; Properties of mouse leukemia viruses. X. Occurrence of viral structural antigens on the cell surface as revealed by a cytotoxicity test. Virology 69:157–169
    [Google Scholar]
12. Hunsmann G., Schneider J., Schulz A. 1981; Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes. Virology 113:602–612
    [Google Scholar]
13. Koch W., Hunsmann G., Friedrich R. 1983; Nucleotide sequence of the envelope gene of Friend murine leukemia virus. Virology 45:1–9
    [Google Scholar]
14. Lenz J., Crowther R., Straceski A., Haseltine W. 1982; Nucleotide sequence of AKV env gene. Journal of Virology 42:519–529
    [Google Scholar]
15. Liu W. T., Engelman R. w., Trang L. Q., Hau K., Good R. A., Day N. K. 1984; Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia. Proceedings of the National Academy of Sciences, U.S.A 81:3516–3520
    [Google Scholar]
16. Oroszlan S., Nowinski R. C. 1980; Lysis of retroviruses with monoclonal antibodies against viral envelope proteins. Virology 101:296–299
    [Google Scholar]
17. Rowe W. P., Pugh W. E., Hartley J. W. 1970; Plaque assay techniques for murine leukemia viruses. Virology 42:1136–1139
    [Google Scholar]
18. Schäfer W. 1979; The inbred mouse strain STU. Development and properties. Zeitschrift für Naturforschung 34C:306–309
    [Google Scholar]
19. Schäfer W., Schwarz H., Thiel H. J., Wecker E., Bolognesi D. P. 1976; Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias. Virology 75:401–418
    [Google Scholar]
20. Schneider J., Falk H., Hunsmann G. 1980; Envelope polypeptides of Friend leukemia virus: purification and structural analysis. Journal of Virology 33:597–605
    [Google Scholar]
21. Seifert E., Claviez M., Frank H., Hunsmann G., Schwarz H., Schäfer W. 1975; Properties of mouse leukemia viruses. XII. Produktion grösserer Mengen von Friendvirus durch eine permanente Zellsuspen-sionskultur (Eveline-Suspensions-Zellen). Zeitschrift für Naturforschung 30C:689–700
    [Google Scholar]
22. Sun D., Lohmann-Matthes M.-L. 1982; Functionally different subpopulations of mouse macrophages recognized by monoclonal antibodies. European Journal of Immunology 12:134–140
    [Google Scholar]
23. Sutcliffe J. G., Shinnick T. M., Green N., Lerner R. A. 1983; Antibodies that react with predetermined sites on proteins. Science 219:660–666
    [Google Scholar]
24. Tainer J. A., Getzoff E. D., Alexander H., Houghten R. A., Olsen A. J., Lerner R. A. 1984; The reactivity of antipeptide antibodies is a function of the atomic mobility of sites in a protein. Nature; London: 312127–134
    [Google Scholar]
25. Walter G., Doolittle R. F. 1983; Antibodies against synthetic peptides. In Genetic Engineering: Principles and Methods 5 pp. 61–91 Holländer A., Setlow J. K. Edited by New York: Plenum Press;
    [Google Scholar]
26. Wolff L., Scolnick E., Ruscetti S. 1983; Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in the 3′ gp70/p15E encoding region have resulted in unique features in the primary structure of its protein product. Proceedings of the National Academy of Sciences, U.S.A 80:4718–4722
    [Google Scholar]